Related Experiment Video
Updated: Jul 21, 2026

In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues
Published on: March 21, 2017
Gonadotropin-releasing-hormone-receptor antagonists
1Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, Vrije Universiteit Medical Centre, PO Box 7057, 1007MB, Amsterdam, Netherlands.
New GnRH antagonists offer immediate blockade of gonadotropin-releasing hormone (GnRH) effects, providing an effective alternative for assisted reproduction and hormone-dependent conditions. These antagonists show promise in reducing treatment duration and hormone usage.
Area of Science:
- Reproductive endocrinology
- Pharmacology
Background:
- Pulsatile GnRH regulates pituitary LH and FSH secretion, controlling gonadal function.
- GnRH blockade is utilized in assisted reproduction and treating sex-hormone-dependent disorders.
- Traditional methods include GnRH agonist desensitization, but GnRH antagonists offer immediate blockade.
Purpose of the Study:
- To evaluate the clinical utility and efficacy of newly developed GnRH receptor antagonists.
- To compare GnRH antagonists with existing GnRH agonist therapies in various clinical applications.
Main Methods:
- Review of clinical data on GnRH antagonists.
- Comparison of treatment outcomes between GnRH antagonists and agonists in assisted reproduction and prostate cancer.
Main Results:
- GnRH antagonists demonstrate effectiveness comparable to established therapies in assisted reproduction.
- These antagonists offer shorter treatment times, reduced gonadotropin use, and improved patient acceptance.
- Clinical evidence is strongest for assisted reproduction and prostate cancer, with potential applications in endometriosis, uterine fibroids, breast cancer, benign prostatic hyperplasia, and precocious puberty.
Conclusions:
- GnRH antagonists represent a significant advancement in blocking GnRH action.
- They offer a promising, effective alternative to GnRH agonists across various clinical indications.
- Further clinical evidence supports their use, particularly in assisted reproduction and prostate cancer management.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
Related Concept Videos
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake
Antidepressant Drugs: MAOIs and Other Agents